Efficacy of PEG-400 and Systane Artificial Tears (Alcon) on Quality of Vision

This study has been completed.

First Received: February 22, 2008 Last Updated: November 20, 2008 History of Changes

Sponsor:	Bp Consulting, Inc
Information provided by:	Bp Consulting, Inc
ClinicalTrials.gov Identifier:	NCT00627302

Purpose

To evaluate the effect of PEG-400 and Systane on quality of vision after LASIK.

Condition	Intervention	Phase
Myopia	Drug: PEG-400 Drug: Systane	Phase IV

Study Type:	Interventional
Study Design:	Randomized, Double Blind (Subject, Investigator), Parallel Assignment

Resource links provided by NLM:

Further study details as provided by Bp Consulting, Inc:

Primary Outcome Measures:

Secondary Outcome Measures:

Enrollment:	40
Study Start Date:	February 2008
Study Completion Date:	November 2008
Primary Completion Date:	November 2008 (Final data collection date for primary outcome measure)

Arms	Assigned Interventions
2: Active Comparator Systane	Drug: Systane Day of Surgery: Starting 2 hours after surgery Instill one drop in randomized eye every two hours. Day 1-Week 1: Instill one drop in randomized eye four times daily
1: Active Comparator PEG-400	Drug: PEG-400 Day of Surgery: Starting 2 hours after surgery Instill one drop in randomized eye every two hours. Day 1-Week 1: Instill one drop in randomized eye four times daily

Eligibility

Criteria

Inclusion Criteria:

Exclusion Criteria:

Contacts and Locations

Please refer to this study by its ClinicalTrials.gov identifier: NCT00627302

Locations

United States, New York
Ophthalmic Consultants of long Island
Rockville Centre, New York, United States, 11570

Sponsors and Collaborators

Bp Consulting, Inc

Investigators

Principal Investigator:

Eric Donnenfeld, MD

Ophthalmic Consultants of Long Island

More Information

No publications provided

Responsible Party:	Ophthalmic Consultants of Long Island ( Eric Donnenfeld, MD )
Study ID Numbers:	5353
Study First Received:	February 22, 2008
Last Updated:	November 20, 2008
ClinicalTrials.gov Identifier:	NCT00627302 History of Changes
Health Authority:	United States: Institutional Review Board

Keywords provided by Bp Consulting, Inc:

Quality of Vision

ClinicalTrials.gov processed this record on February 08, 2010